Diabetes status and grade of left ventricular ejection fraction as predictors of outcomes in patients with Non-ST-segment elevation myocardial infarction
The role of left ventricular ejection fraction grade in differentiating outcomes of Non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction
Event:
ESC Congress 2025
Topic:
Outcome
Session:
Acute coronary syndromes and pharmacotherapy
Impact of left ventricular ejection fraction on outcomes in non-ST-segment elevation myocardial infarction patients with and without chronic kidney disease
Event:
ESC Congress 2025
Topic:
Epidemiology, Prognosis, Outcome
Session:
Epidemiology, prognosis, and outcome in chronic heart failure (1)
Impact of symptom-to-balloon time on long-term prognosis: a 3-year follow-up study in non-st-segment elevation myocardial infarction patients with complex lesions
Event:
ESC Congress 2024
Topic:
Revascularisation
Session:
Medical and percutaneous treatment of coronary artery disease
Two-year clinical outcomes between statin with ACE inhibitor or ARB in patients with ST-segment elevation myocardial infarction after successful PCI with DES
Angiotensin converting enzyme inhibitor versus angiotensin receptor blockers on the top of calcium channel blocker in development of new-onset diabetes mellitus in hypertensive Korean patients
Event:
ESC Congress 2018
Topic:
Pharmacotherapy
Session:
Hypertension - Risk profiling and treatment